Would you like to receive the latest vacancies in your e-mail box? Create a job alert based on your keyword(s) and preferences.
Share
Genmab
General company profile
Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer. For more than 20 years, Genmab’s vision to transform cancer treatment has driven its passionate, innovative and collaborative teams to invent next-generation antibody technology platforms and leverage translational research and data sciences, fueling multiple differentiated cancer treatments that make an impact on people’s lives. To develop and deliver novel therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. Genmab’s proprietary pipeline includes bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates.
Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.
Our core values are:
• Passion for innovation
• Determination—being the best at what we do
• Integrity—we do the right thing
• We work as one team and respect each other
For more information, please visit Genmab.com and follow us on Twitter.com/Genmab.
Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.
Our core values are:
• Passion for innovation
• Determination—being the best at what we do
• Integrity—we do the right thing
• We work as one team and respect each other
For more information, please visit Genmab.com and follow us on Twitter.com/Genmab.
Company activities:
We are the creators of three marketed products* and have a broad clinical and pre-clinical product pipeline. Genmab's technology consists of validated and proprietary next-generation antibody platforms - DuoBody® for generation of bispecific antibodies; HexaBody®, which creates effector-function enhanced antibodies; HexElect®, which combines two co-dependently acting HexaBody molecules to introduce selectivity while maximizing therapeutic potency; and DuoHexaBody®, which enhances the potential potency of bispecific antibodies through hexamerization.
We are looking for
Employees are our most important resource, and we strive to attract and retain the most qualified people to fulfil our core purpose of improving patients’ lives.
We seek individuals with strong theoretical and practical qualifications, and we aim to provide ongoing development of our employees.
We seek individuals with strong theoretical and practical qualifications, and we aim to provide ongoing development of our employees.
What we have to offer
We aspire to create a company environment which promotes both individual and team performance.
If you are interested in working for Genmab, please write or call our HR department. For an up-to-date overview of our current job positions, please go to www.genmab.com.
If you are interested in working for Genmab, please write or call our HR department. For an up-to-date overview of our current job positions, please go to www.genmab.com.
Company info
Address
Uppsalalaan 15 · 3584 CT Utrecht
Name contactperson
Roos Arya Visser
E-mail
recruitmentnl@genmab.com
Phone number
+31(0)302123123
Number of locations:
4
Website
www.genmab.com
Number of employees
1,300+
Active in sectors
Bio/Life Sciences, Pharma
Type of organisation
Multinational